Mutual funds bought metal, media, telecom, engineering, and pharma stocks in December
Markets finished lower for the sixth consecutive day as hopes of the Goods and Services tax (GST) bill being passed in the current session of the Parliament faded considerably.
Broader markets outperformed with BSE Midcap and BSE Smallcap adding 0.23% and 0.45%, respectively
We have been attempting to guide you, the investor, from not going overboard when it comes to investing in sector funds
Joveo is not like Monster or Naukri.com!
'The group having rice flour and wheat flour showed an increase in glycosylated haemoglobin (HbA1c), and the group that took the jackfruit flour had a significant decrease in HbA1c.' 'Our results showed a decrease in fasting blood glucose (FBG) and postprandial glucose (PPG) after the green jackfruit flour meal.'
Nothing is going to dramatically open up on May 3. There will be too many ifs and buts and terms and conditions and guidelines in leading one's life in various zones, reveals Sheela Bhatt.
To become part of the consumer's monthly shopping cart, Sugar Free has launched new formats and variants and waged war against online venom.
The 30-share Sensex ended 50 points lower at 28,112 and the 50-share Nifty declined 12 points to close at 8,531.
Mutual funds continued to buy into oil and gas, banking and finance, telecom, and media stocks in April
The FIPB rejected two proposals -- Nigeria's Mokeme Chiwetal Izuchukwu and Lanarth Developers Pvt Ltd.
Mutual funds bought pharma, manufacturing, auto, and FMCG stocks in June.
The 30-share Sensex gained 117 points to end above 29,000 at 29,006 while the 50-share Nifty gained 32 points to close at 8,761.
India procured around 5 lakh rapid antibody test kits from the two Chinese firms, Guongzhou Wondfo Biotech and Livzon Diagnostics, and they were distributed to several states reporting rising cases of the coronavirus infection.
The 30-share Sensex ended up 33 points at 27,241.78 and the 50-share Nifty ended up 27 points at 8,200.70.
This is to take head on big American pharmaceutical giants, which in the recent past had launched a strong anti-India campaign against efforts of such companies to provide affordable health care not only to people in India, but also in the third world countries.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Amazon committed a fresh investment of $3 billion, in addition to the $2 billion it announced in 2014.
Markets snapped their 8-day winning streak.
'Pay-for-delay' settlements between drug patent-holders and generics manufacturers to delay the launch of cheaper generic medicine are increasingly being scrutinised by antitrust regulators
Top ten billionaires in India.
Jeff Bezos of Amazon tops the list for the second consecutive year with networth of $147 billion.
Investors will remain cautious ahead of F&O expiry.
Dying To Survive, on its way to becoming China's biggest box office hit, may compel the Xi Jinping government to change its policy towards Indian pharmaceutical companies, says Tarun Vijay.
'When you are on these drugs, there is a possibility that you come to the hospital late, just by virtue of the fact that you believe that things are going to turn around, because you are on all these medicines.'
Ajit Mishra, vice president, Research, Religare Broking, answers your queries:
In a major boost to Ranbaxy Laboratories' exports to developed countries, the United States has approved marketing of flecainide acetate tablets in the country.
The Sensex ended down 251 points at 27,351 and the Nifty shed 65 points to close at 8,228.
The Indian Medical Association and the Mumbai Association of Medical Consultant have written a letter to Narendra Modi expressing disappointment over his statement during the Bharat ki Baat Sabke saath event in London.
Referring to COVID-19, she said her husband's administration will not stop fighting until there is an effective treatment and vaccine available to everyone.
Kotak Mahindra Bank and Vedanta were the top Nifty gainers.
The 30-share Sensex ended down 261 points at 27,177 and the 50-share Nifty ended down 91 points at 8,214.
The 30-share Sensex and the 50-share Nifty ended flat at the mark of 29,008 and 8,767 respectively.
A late bout of buying in techs and selective gains in cement, pharma, heavyweights and media major Zee saw the Sensex finally finish with a gain of 17 points at 3,630.
In its report 'Global Top Picks', Barclays expects the current bull market in global equities to continue, generating a total return of 9 per cent in 2015.
Close to three dozen companies will launch their IPOs over the next four-six months.
ICICI Bank was the top gainer in the Sensex pack, surging 4.64 per cent, followed by Axis Bank at 3.86 per cent and SBI 2.53 per cent.
